A total of 3,923 incentive drugs, which have been endorsed by bioequivalence tests, are available for substitute dispensing as of October 2008, up 213 items compared to 3710 in July, according to data released by the Health Insurance Review and Assessment Service (HIRA).
A HIRA official said that the number of incentive drugs is expected to surpass 4,000 sooner or later.
Under the current...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.